Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy
Resource Type
Article
Authors
Du, L. ; Yau, C. ; Brown-Swigart, L. ; Gould, R. ; Krings, G. ; Hirst, G.L. ; Bedrosian, I. ; Layman, R.M. ; Carter, J.M. ; Klein, M. ; Venters, S. ; Shad, S. ; van der Noordaa, M. ; Chien, A.J. ; Haddad, T. ; Isaacs, C. ; Pusztai, L. ; Albain, K. ; Nanda, R. ; Tripathy, D. ; Liu, M.C. ; Boughey, J. ; Schwab, R. ; Hylton, N. ; DeMichele, A. ; Perlmutter, J. ; Yee, D. ; Berry, D. ; van't Veer, L. ; Valero, V. ; Esserman, L.J. ; Symmans, W.F.
Source
In Annals of Oncology May 2021 32(5):642-651
Subject
Breast tumors
Language
ISSN
0923-7534